Wednesday, 10 March 2010

Book now for top scientist's appearance (Wednesday, 10 March 2010) REGISTRATIONS are now open for the free 2010 Graeme Clark Oration to be delivered by genomics pioneer Dr J Craig Venter in Melbourne next week. Full Story...

Tuesday, 9 March 2010

Program Manager – Food Technology (Tuesday, 9 March 2010) An opportunity exists for a part time Program Manager at AusBiotech. Full Story... Giaconda shifts ground on AMTI deals (Tuesday, 9 March 2010) GIACONDA has been forced to revise both the terms of an investment from Australian Medical Therapy Investments and a deal with AMTI for the sale of its Myoconda intellectual property. Full Story... NHMRC awards ‘best and brightest’ (Tuesday, 9 March 2010) FIFTEEN of Australia’s distinguished health researchers were acknowledged for outstanding contribution to medical research at the third annual National Health and Medical Research Council award ceremony held last week. Full Story... ImpediMed wins US reimbursement code (Tuesday, 9 March 2010) IMPEDIMED has won a unique reimbursement code for the use of its bioimpedance spectroscopy technology in the US, with the American Medical Association granting a Category 3 Current Procedural Terminology Code (CPT) to the technology. Full Story... CathRx turns to devices, partnerships (Tuesday, 9 March 2010) AS cardiac catheter manufacturer CathRx’s new chief executive officer settles in, the company has refocused its resources on reusable medical devices, signing an agreement with its German distributor which it expects to formalise by April. Full Story... Analytica grabs FDA approval (Tuesday, 9 March 2010) MEDICAL Australia partner Analytica has received United States Food and Drug Administration approval to market its AutoStart Burette medical device in the US. Full Story... Pipeline Progress: Benitec, NuSep, Alchemia, Xenome (Tuesday, 9 March 2010) THERAPEUTICS developer Benitec and partner CSIRO have requested an oral hearing before the United States Board of Patent Appeals and Interference after the US Patent and Trademark Office answered its appeal against a patent ruling. Full Story... Results trickle in from BioMD children’s trial (Tuesday, 9 March 2010) BIOMD has reported positive interim results from a South African Phase 2 human trial of its bovine CardioCel biomaterial patch in children. Full Story... Bio Briefs: Unilife, Cardia Bioplastics, SafetyMed, pSivida, Aquacarotene (Tuesday, 9 March 2010) THE Australian Taxation Office has granted tax relief to investors in recent North America emigrant Unilife Corporation. Full Story... Business development experts gather for AusBiotech forum (Tuesday, 9 March 2010) MORE than 100 biotechnology business development professionals and experts gathered in Adelaide last week for the AusBiotech 2010 Business Development Workshop and Forum. Full Story...

Monday, 8 March 2010

Market Pulse: The S&P Midas touch (Monday, 8 March 2010) FRIDAY morning brought good news for nine biotechs on BTN’s life science watchlist – eight were named as upcoming additions to the All Ordinaries lineup while another was flagged for the S&P-ASX 300 list. Full Story... Bio Briefs: ImpediMed, Biota, Mesoblast *UPDATED* (Monday, 8 March 2010) IMPEDIMED’S trading halt has been lifted after the American Medical Association granted its lymphoedema early detection device a new emerging technology code for breast cancer, in a move expected to lead to better uptake of the device and more streamlined payments by health insurers. Full Story...

Thursday, 4 March 2010

Accountants kill biotech innovation: UQ (Thursday, 4 March 2010) A TEAM of innovation experts has named the number one enemy of biotech innovation – accountants and their pesky love of costing and evaluating projects up-front. Full Story... Medical Australia rejigs board, senior management (Thursday, 4 March 2010) MEDICAL products manufacturer and distributor Medical Australia has replaced its chairman with corporate finance veteran Thomas Hartigan and appointed former Mylan senior executive Mark Donnison as its new chief executive officer. Full Story... OPINION: Eli Lilly & Company v. Human Genome Sciences (Thursday, 4 March 2010) THE strength and value of many pharmaceutical patent portfolios may be threatened by a United Kingdom appeals court’s recent decision to uphold a judgement to strike down a gene sequence patent. By Wrays Intellectual Property patent attorneys Dr Vicky Longshaw and Gary Cox. Full Story... More data on pSivida’s drug delivery device (Thursday, 4 March 2010) PSIVIDA’S development partner for ophthalmic drug delivery device Iluvien has reported more data from the Phase 3 studies on the use of the device in treating diabetic macular edema. Full Story... Cellmid gets Pharmahungary (Thursday, 4 March 2010) CELLMID has signed a collaboration agreement with Hungarian pharmaceutical company Pharmahungary for the codevelopment of midkine as a heart attack treatment. Full Story... Biotech stars acknowledged (Thursday, 4 March 2010) TWO biotechnology personalities were recognised for their achievements at the BioSA Bioscience Achievement Awards last night, with Dr Deborah Rathjen taking home the Bioscience Industry Leader award while Fiona Khor was named 2010 Young Achiever. Full Story... Stirling eyes contracts for new plant (Thursday, 4 March 2010) HEALTHCARE developer Stirling Products is in discussions to pick up contract manufacturing opportunities for the “near-new” pharmaceutical facility in Cape Breton, Canada, which it has bought for a bargain $C3.6 million ($A3.9 million). Full Story... Giaconda drug back in development (Thursday, 4 March 2010) GIACONDA has a drug back in development, in the first positive news for the struggling life science company in some time. Full Story... Bio People: Stirling, Sienna (Thursday, 4 March 2010) PROFESSOR Glyn M Tonge of Southampton Solent University, who was previously Baring Brothers’ global head of pharmaceuticals and healthcare, has joined Stirling Products as a non-executive director. Full Story... Report on HTA prompts changes (Thursday, 4 March 2010) THE federal government is pledging reforms to streamline processes and reduce the cost of assessing new medical technologies in Australia after a report on health technology assessment was released. Full Story...

Click here to read today's news stories.

Click here to read our complete archive.